NIH-funded research NIH-funded research

Understanding how skin cells exchange harmful chemicals to cause injury and wound repair

Official title: Understanding mechanisms of cell-cell exchange of topically exposed chemicals of concern provoking human skin injury, hypodermal damage, and wound disrepair

Funded at University of Pittsburgh at Pittsburgh · NIH-11451670 · Data updated 2026-11-12

A research project aims to uncover how certain chemical agents damage human skin and what happens in the early stages of blistering and inflammation.

More Wound research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startAugust 18, 2026
Project endJuly 31, 2029
Funding year2026
Award (this year)$235,510
NIH project number1R34AR087022-01A1
Project IDNIH-11451670 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be individuals whose skin tissue could be used for ex vivo models, such as donors providing ethically consented skin specimens for research.

Less likely to help

People without access to tissue donation opportunities or those not involved in tissue-based research may not directly benefit.

What this research studies

The study uses a novel ex vivo human skin model from full-thickness tissue to study how vesicants and corrosive agents disrupt skin structure. Researchers will map early events leading to blistering, focusing on keratinocyte-derived exosomes, mast cell activation, and proteolysis of skin proteins. The work combines advanced biology with human tissue to better explain why injuries progress and persist. This could pave the way for targeted therapies to reduce damage and promote healing after exposure.

Why it matters

Potential benefit: If successful, the research could guide new treatments to lessen skin injury from chemical exposures and speed recovery.

How similar studies have gone: Previous ex vivo skin models have shown promise in replicating human skin responses more accurately than animal models.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Ghatak, Subhadip — University of Pittsburgh at Pittsburgh
  • Study coordinator: Ghatak, Subhadip

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.